ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
97 804,53
-0,41%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Abattis Bioceuticals Corporation (CE) (ATTBF) Cours

Abattis Bioceuticals Corporation (CE)

Abattis Bioceuticals Corporation (CE) (ATTBF)

USOTC
0,000001
0,00
(0,00%)
Fermé 05 Janvier 10:00PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,000001
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,000001 Plage de 52 semaines 0,000134
Clôture Veille
0,000001
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
49 806
Volume financier
-
VWAP
-

ATTBF Dernières nouvelles

Plus de nouvelles

S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports

S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports PR Newswire NEW YORK, March 25, 2015 NEW YORK, March 25, 2015 /PRNewswire/...

25 Mars 2015
PR Newswire (US)

ANALYST REPORTS ON COMPANIES ANNOUNCING GAME CHANGING DEVELOPMENTS

  Burton, MI - October 02, 2014 - InvestorsHub NewsWire - Anavex Life Sciences Corp. (OTCQB: AVXL) is a clinical-stage biopharmaceutical company engaged in the development of novel drug...

02 Octobre 2014
InvestorsHub NewsWire

OTC Markets Group Welcomes Abattis Bioceuticals to OTCQX®

OTC Markets Group Welcomes Abattis Bioceuticals to OTCQX® PR Newswire NEW YORK, July 11, 2014 NEW YORK, July 11, 2014 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open...

11 Juillet 2014
PR Newswire (US)

Industrial Hemp and Medical Marijuana Industry Gather for GreenRush Financial Conference in Vancouver

VANCOUVER,B.C., May 5, 2014 (GLOBE NEWSWIRE) -- A hundred and fifty years ago, Harry Barr's (President and CEO of Next Gen Metals) (CSE:N) (OTC Pink:NXTTF), ancestors began farming in the Ottawa...

05 Mai 2014
GlobeNewswire Inc.

Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project

Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project Sponsorship will fund completion of monograph to guide commercial production in Canada PR...

12 Mars 2013
PR Newswire (US)

Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resist...

Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resistance PR Newswire VANCOUVER, British Columbia, March 8, 2013 VANCOUVER...

08 Mars 2013
PR Newswire (US)

Abattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea

Abattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea PR Newswire VANCOUVER, British Columbia, March 6, 2013 VANCOUVER, British Columbia, March 6, 2013...

06 Mars 2013
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1001.0E-61.0E-61.0E-6577001.0E-6CS
4001.0E-61.0E-61.0E-6859921.0E-6CS
12001.0E-61.0E-61.0E-6498061.0E-6CS
26001.0E-60.0001341.0E-6350791.14E-6CS
52001.0E-60.0001341.0E-6243801.16E-6CS
156-9.0E-6-901.0E-50.0011.0E-6208002.07E-6CS
260-0.005299-99.98113207550.00530.0771.0E-63289840.01370283CS

ATTBF - Frequently Asked Questions (FAQ)

What is the current Abattis Bioceuticals (CE) share price?
The current share price of Abattis Bioceuticals (CE) is US$ 0,000001
What is the 1 year trading range for Abattis Bioceuticals (CE) share price?
Abattis Bioceuticals (CE) has traded in the range of US$ 0,000001 to US$ 0,000134 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
EGIOQEdgio Inc (CE)
US$ 0,01
(999 900,00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,008
(799 900,00%)
477
THCBFTHC Biomed International Limited (CE)
US$ 0,001
(99 900,00%)
100
AEORFAEON REIT Investment Corporation (PK)
US$ 796,08
(26 436,00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
US$ 0,0002
(19 900,00%)
225
UFABQUnique Fabricating Inc (CE)
US$ 0,000001
(-99,98%)
102,53k
VICFFVice Health and Wellness Inc (CE)
US$ 0,000001
(-99,97%)
996
SAFSSafer Shot Inc (CE)
US$ 0,000001
(-99,93%)
2,54M
ERFBERF Wireless Inc (CE)
US$ 0,0001
(-99,89%)
99,77k
ARVLFArrival (CE)
US$ 0,0002
(-99,60%)
42,86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,0038
(52,00%)
608,97M
HMBLHUMBL Inc (PK)
US$ 0,0009
(0,00%)
546,25M
PHILPHI Group Inc (PK)
US$ 0,0003
(0,00%)
501,07M
CBIACanopus Biopharma Inc (PK)
US$ 0,0002
(100,00%)
281,95M
RDARRaadr Inc (PK)
US$ 0,00125
(-10,71%)
169,44M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
ATTBF
Abattis Bioceuticals (CE)
LSE
NCCL
Ncondezi Energy
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés